{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:14:27Z","timestamp":1790885667112,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejso.2022.11.010","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T20:47:08Z","timestamp":1667940428000},"page":"550-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Two stage hepatectomy (TSH) versus ALPPS for initially unresectable colorectal liver metastases: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-0501","authenticated-orcid":false,"given":"Tamara","family":"D\u00edaz Vico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Granero Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alcover Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Su\u00e1rez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-4601","authenticated-orcid":false,"given":"Luka","family":"Mihic G\u00f3ngora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-1340","authenticated-orcid":false,"given":"Eva Mar\u00eda","family":"Montalv\u00e1 Or\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6378-498X","authenticated-orcid":false,"given":"Javier","family":"Maupoey Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3274-9860","authenticated-orcid":false,"given":"Nuria","family":"Tru\u00e1n Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gonz\u00e1lez-Pinto Arrillaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Electo","family":"Granero Tranc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.11.010_bib1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"House","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1186\/1471-2407-14-810","article-title":"Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma","volume":"14","author":"Hackl","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.11.010_bib3","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1200\/JCO.2012.44.8308","article-title":"Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases","volume":"31","author":"Ye","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/annonc\/mdu088","article-title":"Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX\/cetuximab or FOLFIRI\/cetuximab in a multidisciplinary concept (CELIM study)","volume":"25","author":"Folprecht","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ejso.2016.05.038","article-title":"FOLFIRI plus cetuximab in patients with liver-limited or nonliver-limited RAS wild-type metastatic colorectal cancer: a retrospective subgroup analysis of the CRYSTAL study","volume":"42","author":"K\u00f6hne","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1245\/s10434-014-4094-7","article-title":"A\u00a0multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808)","volume":"22","author":"Uetake","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11523-015-0377-6","article-title":"ETNA study group. Secondary metastases resection after bevacizumab plus irinotecan-based chemotherapy in first-line therapy of metastatic colorectal cancer in a real-life setting: results of the ETNA cohort","volume":"11","author":"Rouyer","year":"2016","journal-title":"Targeted Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2017.10.028","article-title":"Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3","volume":"88","author":"Modest","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.11.010_bib9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ejca.2014.02.024","article-title":"Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer","volume":"50","author":"Jones","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.11.010_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/bjs.8835","article-title":"Effect of specialist decision-making on treatment strategies for colorectal liver metastases","volume":"99","author":"Jones","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib12","first-page":"521","article-title":"Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report","volume":"107","author":"Makuuchi","year":"1990","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.sla.0000145965.86383.89","article-title":"A\u00a0two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases","volume":"240","author":"Jaeck","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00000658-200012000-00006","article-title":"Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors","volume":"232","author":"Adam","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.surg.2014.12.009","article-title":"A\u00a0systematic review and metaanalysis of portal vein ligation versus portal vein embolization for elective liver resection","volume":"157","author":"Pandanaboyana","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/bjs.9872","article-title":"Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases","volume":"102","author":"Simoneau","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jamcollsurg.2014.01.063","article-title":"Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients","volume":"219","author":"Giuliante","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib19","first-page":"1","article-title":"A\u00a0new method for induction of liver hypertrophy prior to right trisectionectomy: a report of three cases","volume":"13","author":"Baumgart","year":"2011","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2022.11.010_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","article-title":"Early survival and safety of ALPPS: first report of the International ALPPS Registry","volume":"260","author":"Schadde","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/SLA.0000000000003539","article-title":"Defining benchmark outcomes for ALPPS","volume":"270","author":"Raptis","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1477-2574.2012.00596.x","article-title":"Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases","volume":"15","author":"Gr\u0105t","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2022.11.010_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(12)61148-9","article-title":"European surgical outcomes study (EuSOS) group for the trials groups of the European society of intensive care medicine and the European society of anaesthesiology. Mortality after surgery in europe: a 7 day cohort study","volume":"380","author":"Pearse","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.11.010_bib25","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00268-014-2513-3","article-title":"ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis","volume":"38","author":"Schadde","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/hpb.12386","article-title":"Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis","volume":"17","author":"Croome","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2022.11.010_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejso.2015.01.031","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity","volume":"41","author":"Tanaka","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jamcollsurg.2013.03.004","volume":"217","author":"Shindoh","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRIMSA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejso.2022.11.010_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr Clin Trials"},{"key":"10.1016\/j.ejso.2022.11.010_bib31","series-title":"The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.ejso.2022.11.010_bib32","series-title":"R: a language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.ejso.2022.11.010_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Base Ment Health"},{"key":"10.1016\/j.ejso.2022.11.010_bib35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","article-title":"ALPPS improves resectability compared with conventional two-staged hepatectomy in patients with advanced colorectal liver metastases. Results from a Scandinavian multicenter randomized controlled trial (LIGRO trial)","volume":"267","author":"Sandstr\u00f6m","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1245\/s10434-014-4291-4","article-title":"Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy","volume":"22","author":"Ratti","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/bjs.10256","article-title":"Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases","volume":"103","author":"Adam","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib38","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1245\/s10434-016-5419-5","article-title":"Short chemotherapy-free interval improves oncological outcome in patients undergoing two-stage hepatectomy for colorectal liver metastases","volume":"23","author":"Kambakamba","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.11.010_bib39","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s11605-019-04145-9","article-title":"Two-staged hepatectomy and ALPPS for advanced bilateral liver metastases: a tailored approach balancing risk and outcome","volume":"23","author":"Baumgart","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjsurg.2017.08.013","article-title":"Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?","volume":"215","author":"Chia","year":"2018","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib41","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.surg.2015.12.004","article-title":"Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization","volume":"159","author":"Matsuo","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jamcollsurg.2015.05.017","article-title":"Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy","volume":"221","author":"Kremer","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.surg.2016.11.033","article-title":"Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy","volume":"161","author":"Hasselgren","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/hpb.12386","article-title":"Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis","volume":"17","author":"Croome","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2022.11.010_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.surg.2017.10.036","article-title":"Impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on growth of colorectal liver metastases","volume":"163","author":"Kambakamba","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2022.11.010_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1477-2574.2012.00607.x","article-title":"A\u00a0systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases","volume":"15","author":"Lam","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2022.11.010_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/SLA.0000000000001449","article-title":"Failure to achieve a 2-stage hepatectomy for colorectal liver metastases: how to prevent it?","volume":"262","author":"Imai","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib51","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/SLA.0b013e318265fd3e","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?","volume":"256","author":"Aloia","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00268-017-4181-6","volume":"42","author":"Moris","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2022.11.010_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/bjs.8955","article-title":"In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection","volume":"100","author":"Knoefel","year":"2013","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2022.11.010_bib54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.hbpd.2021.08.001","article-title":"From conventional two-stage hepatectomy to ALPPS: fifteen years of experience in a hepatobiliary surgery unit","volume":"20","author":"Maupoey Ib\u00e1\u00f1ez","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ejso.2022.11.010_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.hpb.2018.12.003","article-title":"Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver metastases and small future liver remnants; a translational substudy of the LIGRO-RCT","volume":"21","author":"Rosok","year":"2019","journal-title":"HPB"},{"issue":"3","key":"10.1016\/j.ejso.2022.11.010_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/SLA.0000000000003701","article-title":"ALPPS improves survival compared with TSH in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO","volume":"273","author":"Hasselgren","year":"2021","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322007387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322007387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:56Z","timestamp":1760060696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322007387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0748798322007387"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.11.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two stage hepatectomy (TSH) versus ALPPS for initially unresectable colorectal liver metastases: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}